MTOR and systemic lupus erythematosus: Furthermore, inhibiting the mTOR signal could reverse the abnormal expression of surface molecules (GO:001620) identified by Gene Onotology (GO) analysis among the differentially expressed genes and the SLE signal-related molecules (PATH ID:05322) identified by pathway analysis on M-MDSCs and G-MDSCs in mice with pristane-induced lupus (Fig. S5).